Calcimimetics such as cinacalcet can help reduce parathyroid hormone levels, and hence calcium and phosphorus, in secondary hyperparathyroidism by increasing the sensitivity of calcium sensing receptors in parathyroid gland [18]. This evidence concerns the gene CASR and secondary hyperparathyroidism.